Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Triple Negative Breast Neoplasms × Levoleucovorin × 90 days × Clear all

Sponsor

Conditions

Leukemia, Biphenotypic, Acute 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Burkitt Lymphoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 41 Carboplatin 22 Paclitaxel 21 Specimen Handling 16 Biopsy 14 Magnetic Resonance Spectroscopy 13 Cyclophosphamide 12 Capecitabine 10 130-nm albumin-bound paclitaxel 9 olaparib 8 Doxorubicin 8 Albumin-Bound Paclitaxel 8 Gemcitabine 7 eribulin 6 sacituzumab govitecan 5 Taxes 5 Bevacizumab 5 toripalimab 4 atezolizumab 4 Standard of Care 4 Nivolumab 4 Injections 4 Drug Therapy 4 Docetaxel 4 liposomal doxorubicin 3 durvalumab 3 capivasertib 3 X-Rays 3 Radiation 3 Platinum 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡